Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

🔍
AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

2 articles matching "Becker muscular dystrophy"

NewsRSS3 days ago

Exploring other mobility devices when a walker is no longer sufficient

A person with facioscapulohumeral muscular dystrophy (FSHD) is finding it harder to move around their home with a walker and is exploring other mobility options. They recently visited different places to look for solutions that might work better for their situation. This article discusses the process of finding new mobility devices when current ones stop working well enough.

WHY IT MATTERSPeople with FSHD often face progressive mobility challenges, and knowing what alternative devices exist can help maintain independence and quality of life as the disease progresses.
ℹ Good to knowFacioscapulohumeral muscular dystrophyRead →
AdvocacyRSS3 days ago

Collaboration aims to improve design of FSHD clinical trials

Three organizations that work with facioscapulohumeral muscular dystrophy (FSHD) patients are joining together to make clinical trials better. FSHD is a rare muscle disease that causes weakness in the face, shoulders, and upper arms. This partnership wants to improve how these trials are designed so they can test new treatments more effectively.

WHY IT MATTERSBetter-designed clinical trials mean faster progress toward treatments for FSHD, and patient input through the FSHD Society ensures trials are structured in ways that actually work for people living with the disease.
ℹ Good to knowFacioscapulohumeral muscular dystrophyRead →

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases